KL and breast cancer: Compared with serum Klotho in the first tertile, serum Klotho in the second tertile and third tertile were related to a decreased risk of these cancers, except for the breast cancer (p = 0.4468) and the second tertile of digestive cancer [OR (95%CI):0.602 (0.334,1.085)].